RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-11.23%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$696M
AUM Growth
+$696M
(-25%)
Cap. Flow
-$44.9M
Cap. Flow
% of AUM
-6.45%
Top 10 Holdings %
Top 10 Hldgs %
54.99%
Holding
75
New
17
Increased
7
Reduced
15
Closed
28
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$22.7M |
| 2 |
Neurogene
NGNE
|
$21.6M |
| 3 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$20M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$19.3M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12.6M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$20.2M |
| 2 |
Dynavax Technologies
DVAX
|
$17.9M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$16.1M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$14.9M |
| 5 |
AGEN
Agenus
AGEN
|
$13.8M |
Sector Composition
| 1 | Healthcare | 85.07% |
